Because of CRS and neurologic toxicity risk, the therapy is available through a REMS program.
Nearly 63% of newly diagnosed patients have advanced colorectal cancer, which requires more aggressive treatment and reduces the associated 5-year survival rate.
Approval of a novel antibody-drug conjugate ushers in new second-line option.
As few as one-third of individuals who are living with peripheral artery disease are receiving medical therapies to address their risk factors.
PrEP therapy has revolutionized HIV treatment by protecting patients who are high risk for acquiring the virus.
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.
This guide discusses the integration of continuous glucose monitoring (CGM) technology into clinical practice, emphasizing the role of pharmacists in selecting and optimizing CGM devices for patients.
Legislation allowing pharmacists to prescribe contraceptives is becoming more widespread.
Key opinion leaders examine the pivotal clinical data that supported the FDA approvals of PCV15, PCV20, and PCV21, while also explaining the differences between polysaccharide and conjugate pneumococcal vaccines in terms of their induced immune responses and the durability of protection they offer.
Many pharmacists must find a way to vaccinate hundreds of patients in an organized way, while still having to run an understaffed pharmacy.
Implementing screening and testing services by pharmacists will expand access to care for patients.
The COVID-19 pandemic has led to significant innovation, which presents a unique opportunity for pharmacists to advance pharmacy practice by serving as the integral drug monitoring experts of the health care team.
The panelists provide guidance on how pharmacists should advise patients on recognizing RSV symptoms that require urgent medical attention.
Aspirin, known as acetylsalicylic acid, has been marketed in ways that have de-emphasized potential risks to children.
It is important for pharmacists to understand implications related to drug clearance to maximize therapeutics in patients with kidney disease.
“There is method to this madness” describes routines that affect adherence to medication regimens.
The tool consolidates and highlights key features that would be considered when choosing a biosimilar adalimumab.
Clinical testing of COVID-19 vaccine efficacy has led to the first FDA-approved COVID-19 vaccine, Comirnaty.
Data shed light on brentuximab vedotin plus nivolumab, bendamustine, or gemcitabine.
Combining strong evidence-based recommendations with caring, compassionate, and frequent counseling opportunities hopefully will increase vaccine acceptance and ultimately reduce the incidence of HPV and associated cancers among our patients.
Pharmacists can help to interpret HbA1c and glucose results when patients come to pick up medications and contact prescribers and/or make recommendations based off patient results.
In the pharmacy, time is the ultimate value-add.
The growing awareness in health care of the challenges associated with proper dosing of anticoagulants such as heparin has inspired the emerging field of anticoagulation stewardship.
The shift is intended to maintain uninterrupted access to PrEP, crucial for preventing HIV, and highlights the ongoing efforts to end the HIV epidemic by improving public health outcomes.
Care Coach program offers a comprehensive set of pharmacy and counseling services to patients struggling to manage their diabetes.
Data analysis can help hospitals address waste of controlled substances that fuels diversion and increased costs.
Due to the high-touch, high-risk nature of specialty medications, specialty pharmacies must incorporate robust programs to ensure proper medication usage and minimize the potential for error or adverse events.
Molnupiravir (Lagevrio) is a potent ribonucleoside analog that blocks SARS-CoV-2 replication by acting as a competitive substrate of virally-encoded RNA-dependent RNA polymerase.
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.